Mahatme Sandesh has filed 5 insider transactions across 2 companies since May 2024.
Most recent transaction: a disposition of 694137 shares of Vor Biopharma Inc. ($VOR) on December 05, 2025.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec. 5, 2025 | Vor Biopharma Inc. | $VOR | Mahatme Sandesh | CFO | D | Common Stock | 694137 | $0.00 | 0.0000 | 10,410,630 | 100.00% | 6.67% |
| Dec. 5, 2025 | Vor Biopharma Inc. | $VOR | Mahatme Sandesh | CFO | A | Employee Stock Option (right to buy) | 1388274 | $0.00 | 1,388,274.0000 | 10,410,630 | 9999.99% | 13.34% |
| July 9, 2025 | Vor Biopharma Inc. | $VOR | Mahatme Sandesh | CFO | A | Common Stock | 13882750 | $0.00 | 13,882,750.0000 | 124,851,547 | 9999.99% | 11.12% |
| June 5, 2025 | CRISPR Therapeutics AG | $CRSP | Mahatme Sandesh | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 85,774,474 | 9999.99% | 0.02% |
| May 30, 2024 | CRISPR Therapeutics AG | $CRSP | Mahatme Sandesh | Not found | A | Stock Option (Right to Buy) | 13000 | $0.00 | 13,000.0000 | 0 | 9999.99% | 0.00% |